Genentech | Case Study
Genentech is a large biotech company with digital focus areas in Oncology, Neuroscience, Inflammation, and Respiratory diseases.“There is great value in having DATAcc as an easily accessible resource that can quickly surface data on one aspect of value that inclusivity brings to the business. “ Celine Marquez, MDGlobal Medical Director, Digital Health, Genentech
We needed a foundational resource to point our study teams to when designing a digital trial.
The ResourcesWe provided our study teams with the DATAcc Inclusivity Toolkit for Development to increase inclusive and diverse patient representation in our digital trials.
The Impact✓ Greater patient centricity,
✓ Clear communication with internal teams and executives,
✓ Team education and cohesion,
✓ Refined/improved strategy,
✓ Operational efficiencies,
✓ More buy-in,
✓ Meeting strategic imperative regarding inclusivity.
The Digital Medicine Society (DiMe) is a global non-profit and the professional home for all members of the digital medicine community. Together, we drive scientific progress and broad acceptance of digital medicine to enhance public health.
90 Canal Street, 4th Floor
Boston, Massachusetts 02114
Support UsDonate Here